kaal:position:2026-07-31-5436

Constitutive Activity among Orphan GPCRs: Molecular Mechanisms and Pharmacological Perspectives should be assessed against Kaal's source-bound claim that No regulatory processes or data evaluation capabilities currently exist that could carry out the cross-validated analyses and support the anticipatory regulatory action the authors propose. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

as of 2016 in the United States regulatory system
External evidence level: abstract indexed.
Mapping review tier: ambiguity triage before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Constitutive Activity among Orphan GPCRs: Molecular Mechanisms and Pharmacological Perspectives

Scholarly basis

kaal:claim:2808132-049
Wulf A. Kaal, Erik P.M. Vermeulen, How to Regulate Disruptive Innovation - From Facts to Data (2016). SSRN: https://ssrn.com/abstract=2808132
Source PDF sha256: 3515f2317ed9c1d33ae55d70467cdf1f6c4e350065ea6a887d5d7619599ad7d2

Evidence and mapping

Evidence: abstract indexed
Review tier: ambiguity triage before claim review
Mapping confidence: 0.2062
Mapping ambiguous: true

Topics

institutional-designdynamic-regulation

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0022 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: af246f9cd78a4974a76468634020014924f52e312910aa644bd7ab9bfcb0c49f
curl -s https://wulfkaal.github.io/positions/2026-07-31-5436.md | sha256sum